Valuations made over a number of years and subject to audit each year put the mature trees product at $4500 per ... for heartwood oil.
Pharma valuations - depends upon success of Phase 3 trial and Phase 2 multiple studies progressing at the FDA.
Other revenue - use of non heartwood product - depends upon previous sales and audited assessments.
Value of trained staff and steady rise in ROE per tree.
Point is SDE - this is a LONG term investment where patience and time are needed. So if it takes until November to achieve a result it will take till then.
I am happy to wait and prefer the assessments made by professionals in Australia over hatchet jobs made under the protection of the first amendment,,,
All Imo and DYOR
- Forums
- ASX - By Stock
- QIN
- So what happened to the Aug 4th put deadline?
So what happened to the Aug 4th put deadline?, page-5
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QIN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online